Clinical Trial Update: Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing MediWound's enzymatic debridement to standard of care in burn patients has completed, providing an update on study status and d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Injuries

Drugs mentioned

• NEXOBRID (ANACAULASE-BCDB)

Snippet

Sponsor: MediWound Ltd | Conditions: Burn | Phase 3 | Status: COMPLETED